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Using high-sensitivity assays for C-reactive protein (hsCRP), 
CRP levels have been noted to be elevated in patients with os- 
teoarthritis (OA) and have been associated with disease progres- 
sion as well as with clinical severity and pain in OA. However, 
the mechanistic link between elevated hsCRP levels and disease 
activity remain unclear. 
Aim: Therefore, the aim of this study was to investigate the re- 
lationship between systemic hsCRP and local inflammatory find- 
ings in the joints of patients with hip and knee OA. As IL-6 is a 
known regulator of the acute phase response, we measured both 
systemic and synovial fluid IL-6 levels in these patients. 
Methods: Plasma and synovial membrane specimens from 
52 patients undergoing total knee or hip arthroplasty or knee 
arthroscopy were obtained. Joint fluid samples were obtained 
from a subgroup of 26 patients prior to surgery. H&E stained sec- 
tions were reviewed and scored for degree of inflammatory infil- 
trates using an institutional grading system. High-sensitivity CRP 
levels were measured in plasma, and IL-6 levels in plasma and 
synovial fluid, by ELISA. 
Results: Histologic analysis revealed that 26 patients (50%) with 
idiopathic OA had low grade inflammatory infiltrates, and 4 pa- 
tients (7%) had high grade inflammatory infiltrates. Patients with 
synovial infiltrates had no significant differences in mean age, 
BMI, or gender compared with those without, although there was 
a trend toward slightly higher BMI in the group with histologic 
infiltrates. The mean hsCRP level in the OA group with inflam- 
matory infiltrates was significantly higher compared to the OA 
group without inflammation (4.7 i~g/ml vs. 1.7 i~g/ml, p=0.003). 
Furthermore, the degree of inflammatory infiltration had a statis- 
tically significant correlation with systemic hsCRP levels (r= 0.42, 
p=0.0015). Although plasma IL-6 levels were difficult o detect in 
most OA patients, the average synovial fluid IL-6 level was 88.02 
pg/ml 4- 124.74. A strong and statistically significant correlation 
was found between systemic hsCRP levels and synovial fluid IL-6 
in OA patients (r=0.63, p = 0.005). There were modest but signifi- 
cant correlations between hsCRP and body mass index (r= 0.31, 
p = 0.02). Multiple linear regression analysis revealed that both 
BMI and degree of inflammatory infiltrates were significantly as- 
sociated with hsCRP level (r 2 = 0.221, p = 0.02 for BMI and p = 
0.009 for degree of inflammatory infiltrates). 
Conclusions: Taken together with results from studies linking el- 
evated CRP with more rapid disease progression and pain, this 
suggests that OA patients with elevated hsCRP may form a sub- 
group of patients with synovial inflammation and with a more ag- 
gressive form of disease. The significance of the association with 
BMI is unclear, but suggests that patients with elevated BMI may 
be more likely to develop inflammation within the joint. 
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Aim of Study: To develop and validate an immunoassay for de- 
tection of C-telopeptides of type II collagen (CTX-II) in rodent 
serum samples, and to identify proteases generating the CTX-II 
fragments. 
Methods: Monoclonal antibody F46, raised against the amino 
acid sequence EKGPDP originating from the C-terminal telopep- 
tide of type II, was used both as capture and detecting antibody 
in a sandwich immunoassay. The sandwich construction ensures 
reactivity to cross-linked CTX-II fragments, exclusively. 
Articular cartilage was obtained from a two year old bovine, chon- 
drocytes were inactivated by freezing at -80°C, and subsequently 
the tissue was incubated over night with MMP 9 and 13, with 
and without he MMP-inhibitor GM6001. In other experiments, ar- 
ticular cartilage was cultured for 18 days in the presence of the 
catabolic ytokines TNFo~ and oncostatin M (OSM), with and with- 
out GM6001 and the cysteine-inhibitor E64. The release of col- 
lagen fragments was measured by immunoassay and collagen 
degradation was demonstrated in situ by immunohistochemical 
detection. 
Finally, 24 virgin female Sprague-Dawley rats 6-months old were 
randomly divided into two groups to undergo either bilateral 
ovariectomy or sham operation. Serum samples were obtained at 
baseline and weeks 2, 4, 6, 8 and 10 after ovariectomy. Acceler- 
ated destruction of articular cartilage has previously been demon- 
strated in this animal model (Hoegh-Andersen et al., Arthritis Res 
Ther 2004; 6: R169-R180). 
Results: The preclinical serum CTX II had both inter- and intra- 
assay CVs below 8.0%, and the dilution recovery was 99% (range 
83-106%). The measuring range was 0-300 pg/ml. Supernatants 
originating from MMP 9 and 13 treated cartilage contained 1334.9 
and 4475.7 pg/ml of CTX-II, respectively. The release of CTX-II 
from MMP 9 and 13 treated cartilage could be completed inhib- 
ited by addition of the MMP-inhibitor GM6001. Cultures of bovine 
articular cartilage released 3195 ng/ml of CTX-II after 14-16 days 
of culture in the presence of TNFo~ and OSM. The MMP-inhibitor 
reduced the release to less than 30% (p<0.05), whereas the cys- 
teine inhibitor E64 only induced an 8% decrease (not significant) 
in CTX-II release from the explants. Collagen degradation was 
demonstrated in the superficial ayers of the cartilage explants, 
with high intensity around the chondrocytes. 
Ovariectomy induced a 99% increase in serum CTX-II levels two 
weeks after operation, and the CTX-II level remained significantly 
elevated compared to sham throughout the study period. 
Conclusions: The CTX-II sandwich assay detects type II colla- 
gen fragments generated by the action of MMP9 and MMP13. 
In contrast, the action cysteine proteases did not generate 
molecules reactive in the test, suggesting that these proteases 
did not cleave the collagen molecule at sites exposing the appro- 
priate epitope. Finally, the circulating levels of CTX-II did reflect 
the ovariectomy-induced accelerated cartilage destruction in the 
female rat. 
